CO5 Completeness of Real-World Data (RWD) in Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in United States (US) Community Oncology/Hematology Practices (CH/OS)
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.103
https://www.valueinhealthjournal.com/article/S1098-3015(22)00304-7/fulltext
Title :
CO5 Completeness of Real-World Data (RWD) in Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in United States (US) Community Oncology/Hematology Practices (CH/OS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00304-7&doi=10.1016/j.jval.2022.04.103
First page :
Section Title :
Open access? :
No
Section Order :
10080